50
Participants
Start Date
February 28, 2010
Primary Completion Date
October 31, 2010
Study Completion Date
April 30, 2011
MS14
MS14 will be administered at an oral dose of 25-50 mg/kg/day in two divided doses for three months
Risperidone
The treatment group receives Risperidone 2 mg per day in the beginning which is increased by 1 mg every day until reaching 4 mg/day; this regimen will be continued for three months.
RECRUITING
Iran Psychiatric Training and Treatment Center, Tehran
Lead Sponsor
Farzan Institute
OTHER